News Articles

Takeda to Present Positive Primary Analysis from Phase 2 OPTIC Trial of ICLUSIG® (ponatinib), Reinforcing... OSAKA, Japan & CAMBRIDGE, Mass. -Wednesday 26 May 2021

– OPTIC Trial Evaluating Response-Based Dosing Regimens of ICLUSIG for the Treatment of Resistant / Intolerant Chronic-Phase CML Demonstrates Durable, Clinically Meaningful Depth of Response While Managing Arterial Occlusive Event Risk – Oral Presentation of the OPTIC Primary Analysis at...

Takeda Announces Approval of Moderna’s COVID-19 Vaccine in Japan -Tuesday 25 May 2021

− The Ministry of Health, Labour and Welfare (MHLW) Grants Regulatory Approval of Moderna’s COVID-19 Vaccine (COVID-19 Vaccine Moderna Intramuscular Injection) Following Positive Interim Results in Takeda’s Phase 1/2 Immunogenicity and Safety Clinical Trial − Interim Results Indicate...

INVESTBANK to Launch Next-Generation Credit Card for Jordan Powered by i2c’s Global Processing Platform -Monday 24 May 2021

(BUSINESS WIRE) -- i2c Inc., a leading provider of digital payment and banking technology, today announced a partnership with INVESTBANK, a leading bank in providing innovative financial solutions in Jordan. i2c’s plug-and-play platform will power credit issuing and acquiring capabilities for...

Takeda Presents Updated Results for Mobocertinib, Further Substantiating the Clinical Benefit in Patients with EGFR... -Monday 24 May 2021

(BUSINESS WIRE) -- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced updated data from the Phase 1/2 trial of mobocertinib (TAK-788) orally administered in patients with epidermal growth factor receptor (EGFR) Exon20 insertion mutation-positive (insertion+)...

Mavenir Powering the First Smart City in Thailand With 5G Open RAN Integration Across mmWave Private Network -Sunday 23 May 2021  

End-to-end 5G Private Network with Open RAN capabilities, cloud-enabled 5G Core, orchestration and analytics, and an ecosystem of device and application partners Ban Chang ‘Silicon Beach’ Smart City showcasing today’s technology in partnership with 5GCT, Mavenir and...

Schlumberger Announces Collaboration With AWS to Deploy DELFI Petrotechnical Suite on AWS -Saturday 22 May 2021

(BUSINESS WIRE)-- Schlumberger announced today a collaboration with Amazon Web Services (AWS) to deploy domain centric digital solutions, enabled by the DELFI* cognitive E&P environment, on the cloud with AWS. This collaboration will bring AWS customers to the DELFI Petrotechnical Suite, which...

Foursquare Acquires Geospatial Analytics and Visualizations Platform Unfolded -Saturday 22 May 2021

(BUSINESS WIRE)-- Foursquare today announced its acquisition of Unfolded a next generation platform for geospatial analytics. With the addition of Unfolded’s capabilities to the Foursquare technology stack, enterprises and brands can soon come to Foursquare to not only access its industry...

Data from Merck’s Oncology Portfolio Highlight Significant Advances in Cancer Care at ASCO21 -Saturday 22 May 2021  

New analyses from pivotal BAVENCIO® study reinforce unique clinical benefits across different subgroups in the treatment of advanced urothelial carcinoma New data from VISION study of TEPMETKO® show association between liquid biopsy-identified biomarker and clinical response in METex14...

CHMP issues positive opinion for Jardiance® (empagliflozin) for the treatment of adults with heart... -Friday 21 May 2021  

(BUSINESS WIRE) -- The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending Jardiance® (empagliflozin) for the treatment of adults with symptomatic chronic heart failure with reduced ejection fraction (HFrEF),...

Immuta Announces $90 Million in Series D Funding -Friday 21 May 2021  

(BUSINESS WIRE) -- Immuta, the leading provider of cloud data access control, today announced that it has secured $90 million in Series D funding. Immuta will use the investment to further its market leadership position and capture rising demand for centralized, scalable access control across...

U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients... -Friday 21 May 2021

(BUSINESS WIRE) -- Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food & Drug Administration (FDA) has accepted a New Drug Application (NDA) for maribavir for the treatment of CMV infection in those...

Block.one and Prominent Investors Launch Bullish Global With $10B in Funding, and Announce the 2021 Launch of New... -Friday 21 May 2021  

(BUSINESS WIRE) -- Block.one, the software company behind the EOSIO open-source software, announced today the launch of a newly formed subsidiary, Bullish Global. Operating as an independent entity under the Block.one parent company, Bullish Global is focused on the 2021 planned release of...

Independent Study Shows LiveRamp’s Authenticated Traffic Solution Drives More Than 340% Return on Investment for... -Thursday 20 May 2021

(BUSINESS WIRE)-- LiveRamp® (NYSE: RAMP) the leading data connectivity platform, today announced its Authenticated Traffic Solution (ATS) has been adopted by hundreds of publishers, brands and platforms across the globe, including in the US, UK, France, Italy, Spain, Germany, Australia and...

Q3, FY 2021 Results: Mytheresa Reports Exceptional Net Sales Growth of 47.5% in Q3, FY 2021 Benefiting From the... -Thursday 20 May 2021

Increase in net sales of 47.5% year-over-year to €164.8 million in Q3, FY 2021 Acceleration evident by 66% two-year net sales growth compared to Q3, FY 2019 Continued strong profitability with adjusted EBITDA of €11.1 million compared to €3.1 million in Q3, FY 2020 Full fiscal...

Takeda Delivers Resilient FY2020 Results With Strong Margins & Robust Cashflow; Underlying Revenue Growth Expected... -Thursday 20 May 2021

Delivered FY2020 Management Guidance with Results Driven by +16% Underlying Revenue Growth of 14 Global Brands (e.g., ENTYVIO ® +26.2% YOY, TAKHZYRO® +30.0% YOY, Immunoglobulin + 15.7% YOY) Accelerated Cost Synergies and Achieved $2.3 Billion Target One Year Ahead of Plan Reported Net...

Esri Signs Training Protocol Agreement with Chamber of Geophysical Engineers of Turkey -Wednesday 19 May 2021

(BUSINESS WIRE)-- Esri, the global leader in location intelligence, today announced an agreement with the Chamber of Geophysical Engineers of Turkey (CGET), whereby the chamber's members will be entitled to special discounts on training for Esri's ArcGIS software. Now, all geophysical engineers...

NTT to Donate US$3M for Pandemic Relief to India -Wednesday 19 May 2021

(BUSINESS WIRE)-- NTT (TOKYO:9432) announces today plans to donate US$3 million to support the humanitarian tragedy facing the people of India. In addition to this, the NTT companies are contributing support and services for their employees to help cope with this challenging situation. India...

Andersen Global Broadens Coverage in Liechtenstein and Switzerland -Wednesday 19 May 2021

(BUSINESS WIRE)-- Andersen Global adds legal capabilities in Liechtenstein and Switzerland through a Collaboration Agreement with NSF, strengthening the organization’s platform as it continues its expansion in the region. With offices in Vaduz and Zurich, NSF operates with five Partners and...

CSC Expands Its Funds Services Footprint with New Irish Depositary License -Wednesday 19 May 2021

(BUSINESS WIRE)-- CSC, the world’s leading provider of business, legal, tax, and digital brand services, has secured a specialised depositary license from the Central Bank of Ireland. On the heels of obtaining CSC’s Irish fund administration license last year, the depositary license further...

Stephen Stonberg appointed interim CEO of Bittrex Global -Wednesday 19 May 2021  

(BUSINESS WIRE)-- The Boards of Directors (the “Boards”) of Bittrex Global GmbH (Vaduz, Liechtenstein) and Bittrex Global (Bermuda) Ltd (Hamilton, Bermuda) have confirmed that Tom Albright is stepping down from his role as CEO of both companies effective today. The Boards are grateful for...